Interested in cooperation?
If your company would like to be involved in supporting the work of people with colorectal cancer, Lynch syndrome and their loved ones, please contact sonja.soderholm@colores.fi or tel. 050 5012885. We offer logo space on our website, but new partnership ideas are also very welcome!
Amgen
Amgen is a company founded in 1980 with strong roots in science and innovation, enabling new ideas and breakthroughs in medicines for serious diseases. Amgen has grown from a pioneer in biotechnology to one of the world’s leading biotechnology companies, with a mission to improve patients’ health by focusing on areas of medicine with high unmet treatment needs. We now operate in about 100 countries and have helped millions of people in the fight against cancers, cardiovascular diseases, bone diseases, kidney diseases, and other serious conditions.
For more information about our company and the Amgen team in Finland, visit our website.
Amgen has also produced the “Pieni kirjanen suolistosyövästä” guide in finnish for individuals diagnosed with colorectal cancer and their loved ones.
B.Braun
B. Braun Melsungen AG, the parent company of B. Braun Medical Oy operating in Finland, is one of the largest private companies and the leading healthcare company in the world. The company manufactures and markets medicines and supplies for anaesthesia and intensive care. The company’s products also include surgical supplies, dialysis equipment and supplies, and outpatient products. B. Braun Medical Oy in Finland is one of the Group’s oldest subsidiaries.
For more than 40 years, B. Braun has been actively involved in stoma care research, providing its users and medical staff with innovative solutions through its wide range of dressings and accessories. B. Braun’s stoma care research aims to develop products that improve users’ quality of life. It is important that the products guarantee the user discreetness, a sense of comfort, security and ease of use.
Cancer Society of Finland
The Cancer Society of Finland consists of 12 regional cancer societies and six national patient organisations. The CSF maintains the Finnish Cancer Registry. Cancer Foundation Finland is a charitable organisation and the main private funder of cancer research in the country.
The strategy of the Cancer Society and the Cancer Foundation Finland is their pledge to act decisively to promote health, prevent cancer, support people with cancer and reduce the adverse effects of cancer throughout the country.
Colores is a member association of Cancer Society of Finland.
ConvaTec
Advanced solutions for the patient’s best: ConvaTec is a global healthcare company focused on providing medical devices and supplies for the management of chronic conditions. We are a leader in the areas of wound care, ostomy care, urology, and specialty care, as well as infusion devices. With approximately 10,000 colleagues, and in line with our “Forever Caring” promise, our products and services are available in over 100 countries. Our solutions offer a wide range of benefits, from infection prevention and skin protection for at-risk patients to better clinical outcomes and reduced healthcare costs. The company is part of the FTSE 100 index (LSE:CTEC), and in 2021, revenue exceeded $2 billion.
For more information about ConvaTec, visit
Dansac Hollister
Dansac develops, manufactures and markets unique stoma care products that solve specific problems and improve quality of life for people with a stoma – and for people who work with stoma care. This is our mission!
Dansac focuses solely on stoma care, nothing else. We consider each stoma to be an individual case that requires unique care and products. We do not hesitate to find new ways and to think differently.
Hollister Incorporated is an independent, employee-owned company that develops, manufactures, and markets healthcare products and services worldwide.
We offer advanced medical products for Ostomy Care, which includes two strong global brands – Hollister Ostomy and Dansac Ostomy; Continence Care; Critical Care; and Wound Care. We also provide innovative healthcare programs and services, as well as educational materials for patients and healthcare professionals.
www.dansac.co.uk
www.hollister.co.uk
Digestive Cancers Europe
Digestive Cancers Europe DiCE is the voice of digestive cancer patients in Europe. Its aim is to save lives by bringing together all key stakeholders in the fight against these cancers. We are campaigning for the adoption of best practices in prevention, diagnosis, treatment and follow up.
Colores is a full member of DiCE.
www.digestivecancers.eu
A Guide to caring for someone with Colorectal Cancer
Docrates Cancer Center
Suomen Gastroenterologiplavelut Oy
Suomen Gastroenterologipalvelut Oy offers a comprehensive “Gasendo” colorectal cancer screening service for everyone, as well as high-quality specialist services related to stomach and intestinal diseases.
Merck Oy
Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, and consumer health and animal products. We aspire to being the best healthcare company in the world, and are dedicated to providing leading innovations and solutions for tomorrow. We have made it our mission to provide innovative, distinctive products and services that save and improve lives and satisfy customer needs.
Nordic Drugs – A Nordic Pharmaceutical Company
Nordic Drugs AB is a Nordic pharmaceutical company that was established in 1995. We are headquartered in Malmö, where some of our products are manufactured, and we have sales organizations in Denmark, Finland, Norway, and Iceland. Our company offers a range of highly specialized, proprietary, and licensed products in oncology, rheumatology, pain, addiction care, hematology, women’s health, and gastroenterology.
Over the almost 30 years that Nordic Drugs has been in existence, our company has grown and developed into a stable and well-known supplier in the Nordic pharmaceutical market, characterized by high delivery reliability and well-known, strong brands in both Rx and OTC.
Nutricia Medical
Nutricia Medical, specializing in clinical nutrition, is part of the Danone Group, which manufactures food products. We have developed a broad and unique range of products for various patient groups and different needs. We offer solutions and services to support dietary treatment. Clinical nutrition products are designed for the dietary treatment of disease-related malnutrition, to meet the needs of patients for whom regular food is insufficient or unsuitable as a source of nutrition. These products should be used according to the guidance of healthcare professionals. In collaboration with doctors and other healthcare professionals, we aim to improve patients’ quality of life by supporting their functionality and accelerating recovery.
We work closely in the field of oncology. Our product portfolio includes several options for the dietary treatment of cancer patients. For example, Nutridrink Compact Protein nutritional supplement drinks have been developed in collaboration with cancer patients to address the sensory changes they experience.
Pfizer
Good health is vital to all of us; as are sustainable solutions to the most pressing healthcare challenges we are facing globally. We at Pfizer are committed to applying science and our global resources to develop breakthroughs that change patients’ lives, to improve health and well-being at every stage of life. Our goal is to ensure that people have the opportunity to lead healthier lives with access to effective and innovative treatments when they need them. We aim to bring hope to patients and their loved ones in the midst of illness.
Breakthroughs that change patients’ lives.
Pierre Fabre Pharma Norden
Standing with patients in the fight against cancer.
Pierre Fabre Group is a global company based in France and employing 10,400 people worldwide. To safeguard our independence and long-term focus, as our founder Pierre Fabre intended, a majority stake in the company is held by a not-for-profit foundation.
At Pierre Fabre, we care for the person as a whole. Our products are used to treat various cancers and to alleviate sensitive skin and dermatological side effects that may occur after long-term treatment.
The purpose of our cancer research is to improve the care of patients whose treatment needs are currently going unmet as a result of their condition. We are guided at all times by our core values and the goal of improving individual wellbeing.
Servier
Servier is an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening our first laboratory in 1954, we have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.
We are a leading force in cardiology—number 2 in Europe, number 5 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.
STEA
The Funding Centre for Social Welfare and Health Organisations (STEA) manages the funding granted for projects which are non-profit by nature and promote health and wellbeing, from the gaming revenue of Veikkaus Oy.
The funding granted from Veikkaus Oy’s revenue for projects related to arts, culture, and sports are managed by the Ministry of Education and Culture, and funding for projects related to the promotion of horse breeding and equestrian sports by the Ministry of Agriculture and Forestry.
Takeda Oy
Takeda Oy is the Finnish subsidiary of the Takeda Group, which originated in Japan over 240 years ago. Today, Takeda is a science-driven and digital biopharmaceutical company operating in over 80 countries worldwide.
Takeda’s core mission is to develop and manufacture life-changing medicines that help patients receive the best possible care and support the sustainable development of healthcare.
Our research and business focus on rare diseases, cancer, gastrointestinal diseases, and neurological disorders, as well as targeted plasma-derived therapies and vaccines.
